Institutional Ownership Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID). We have compiled data on the 82 institutions that hold shares in the stock, with a total of 43.2 Million shares, which have been reported (via 13F filing form) to have a value of $33.3 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
145,965
shares
|
$112,393
0.0% of portfolio
|
Q1 2024
New holding
|
|
Empowered Funds, LLC
|
May 07, 2024 Q1 2024 |
128,070
shares
|
$98,613
0.01% of portfolio
|
Q1 2024
Added 18.8%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
May 13, 2024 Q1 2024 |
119,113
shares
|
$91,717
0.0% of portfolio
|
Q1 2024
Added 4.41%
|
|
Assenagon Asset Management S.A.
|
Apr 24, 2024 Q1 2024 |
114,265
shares
|
$87,984
0.0% of portfolio
|
Q1 2024
Added 45.6%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
99,953
shares
|
$76,963
0.0% of portfolio
|
Q1 2024
Reduced 25.37%
|
|
Ea Series Trust
Havertown, PA |
Jul 27, 2023 Q2 2023 |
98,952
shares
|
$76,193
0.01% of portfolio
|
Q2 2023
New holding
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 09, 2024 Q1 2024 |
84,233
shares
|
$64,859
0.0% of portfolio
|
Q1 2024
Added 3.77%
|
|
Rhumbline Advisers
Boston, MA |
May 09, 2024 Q1 2024 |
82,584
shares
|
$63,589
0.0% of portfolio
|
Q1 2024
Added 3.66%
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
73,422
shares
|
$56,534
0.0% of portfolio
|
Q1 2024
Added 2.07%
|
|
Tejara Capital LTD
London, X0 |
May 14, 2024 Q1 2024 |
73,153
shares
|
$56,327
0.08% of portfolio
|
Q4 2023
New holding
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2024 Q1 2024 |
71,264
shares
|
$54,873
0.0% of portfolio
|
Q1 2024
Reduced 8.95%
|
|
Squarepoint Ops LLC
New York, NY |
May 15, 2024 Q1 2024 |
68,343
shares
|
$52,624
0.0% of portfolio
|
Q1 2024
Added 500.5%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2024 Q1 2024 |
62,341
shares
|
$48,002
0.0% of portfolio
|
Q2 2023
Reduced 2.2%
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
58,984
shares
|
$45,417
0.0% of portfolio
|
Q1 2024
Reduced 4.55%
|
|
Jane Street Group, LLC
New York, NY |
May 15, 2024 Q1 2024 |
53,580
shares
|
$41,256
0.0% of portfolio
|
Q1 2024
Added 5.26%
|
|
Bank Of Nova Scotia
|
May 14, 2024 Q1 2024 |
44,152
shares
|
$33,997
0.0% of portfolio
|
Q3 2023
Added 0.3%
|
|
Barclays PLC
London, X0 |
May 15, 2024 Q1 2024 |
42,136
shares
|
$32,444
0.0% of portfolio
|
Q1 2024
Reduced 48.65%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
40,669
shares
|
$31,315
0.0% of portfolio
|
Q1 2024
New holding
|
|
Sg Americas Securities, LLC
|
May 06, 2024 Q1 2024 |
35,938
shares
|
$27,672
0.0% of portfolio
|
Q1 2024
Reduced 9.69%
|
|
Invesco Ltd.
Atlanta, GA |
May 14, 2024 Q1 2024 |
29,554
shares
|
$22,756
0.0% of portfolio
|
Q1 2024
Reduced 1.11%
|
|
American International Group, Inc.
New York, NY |
May 13, 2024 Q1 2024 |
29,386
shares
|
$22,627
0.0% of portfolio
|
Q1 2024
Reduced 0.85%
|
|
First Manhattan CO
New York, NY |
May 15, 2024 Q1 2024 |
26,000
shares
|
$20,020
0.0% of portfolio
|
Q1 2022
Added 225.0%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 14, 2024 Q1 2024 |
25,980
shares
|
$20,004
0.0% of portfolio
|
Q1 2024
Added 4.55%
|
|
Prelude Capital Management, LLC
New York, NY |
May 15, 2024 Q1 2024 |
25,555
shares
|
$19,677
0.0% of portfolio
|
Q1 2024
New holding
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2024 Q1 2024 |
24,135
shares
|
$18,583
0.0% of portfolio
|
Q1 2024
Added 450.65%
|